Phoebe Rich

6.8k citations
126 papers · 4.2k · 1 hit paper · h-index 36

Impact in

  • Dermatology top 0.1%
    • Dermatology and Skin Diseases
    • Cutaneous lymphoproliferative disorders research
    • Acne and Rosacea Treatments and Effects
  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Nail Diseases and Treatments 64
    • Fungal Infections and Studies 11
    • Nonmelanoma Skin Cancer Studies 11
    • Cutaneous lymphoproliferative disorders research 19
    • Acne and Rosacea Treatments and Effects 9

Phoebe Rich

117 papers receiving 4.0k citations

Phoebe Rich's Hit Papers

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial 2022 · 192 citations
1920+1+2Years since publication50100150

Peers

Phoebe Rich
Comparison fields: 5 of 134
  • Dermatology 1.6k
  • Immunology 1.3k
  • Epidemiology 1.8k
  • Cell Biology 653
  • Pathology and Forensic Medicine 495
Replace Jerome L. Shupack with:
Jerome L. Shupack United States
P.M. Farr United Kingdom
G. Borroni Italy
Renato G. Panizzon Switzerland
Nicoletta Cassano Italy
J.L. López‐Estebaranz Spain
Gino Antonio Vena Italy
Sarah Brenner Israel
Jaakko Karvonen Finland
C. Ralph Daniel United States
Phoebe Rich relative to Jerome L. Shupack United States Jerome L. Shupack's profile →
Citations per field
00.5×11.1×
Jerome L. Shupack · 1×
Citations per year

Countries citing papers authored by Phoebe Rich

Since Specialization
Citations

This map shows the geographic impact of Phoebe Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phoebe Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phoebe Rich more than expected).

Fields of papers citing papers by Phoebe Rich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phoebe Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phoebe Rich. The network helps show where Phoebe Rich may publish in the future.

Co-authors

The 25 scholars most cited alongside Phoebe Rich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phoebe Rich Line = papers co-authored together Phoebe Rich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003382
2 2002224
3
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Hit paper breakdown →
2022192
4 2012186
5 2007175
6
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
2003152
7
The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
2007142
8 2015136
9 2015133
10 2007131
11 201990
12 201388
13 200973
14 201771
15 201570
16
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
200568
17 199267
18 201662
19 201361
20 199660

About Phoebe Rich

Phoebe Rich is a scholar working on Epidemiology, Dermatology, Immunology, Pathology and Forensic Medicine and Cell Biology, having authored 126 papers that have together received 4.2k indexed citations. Recurring topics across this work include Nail Diseases and Treatments (64 papers), Psoriasis: Treatment and Pathogenesis (33 papers), Cutaneous lymphoproliferative disorders research (19 papers), Plant Pathogens and Fungal Diseases (15 papers), Autoimmune Bullous Skin Diseases (13 papers), Fungal Infections and Studies (11 papers), Nonmelanoma Skin Cancer Studies (11 papers) and Acne and Rosacea Treatments and Effects (9 papers). The work is most often cited by research in Dermatology (1.6k citations), Immunology (1.3k citations), Epidemiology (1.8k citations), Cell Biology (653 citations) and Pathology and Forensic Medicine (495 citations). Phoebe Rich has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard K. Scher, Boni E. Elewski, David M. Pariser, Helen Torok, Richard Pollak, Julie Jefferson, J.Q. Del Rosso, John K. Geisse, Kenneth G. Gross and Amit G. Pandya. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of Dermatological Treatment, Dermatologic Surgery, Journal of the European Academy of Dermatology and Venereology and Dermatologic Clinics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact